Globeflex Capital L P Protagonist Therapeutics, Inc Transaction History
Globeflex Capital L P
- $1.15 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
254Shares Held
58MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$290 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$281 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$269 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$206 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$163 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.4B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...